SAI - Detailed view

RANIVISIO Inj Lös 2.3 mg/0.23ml Durchstf 0.23 ml

Drug

Name

Ranivisio, Injektionslösung

Field of application

exsudative altersbezogene Makuladegeneration; Visusverlust duch diabetisches Makulaödem, durch Makulaödem infolge eines retinalen Venenverschlusses und durch choroidale Neovaskularisation infolge pathologischer Myopie; aktive, den Visus beeinträchtigende choroidale Neovaskularisation; mässig schwere bis schwere NPDR bzw PDR

ATC

S01LA04 - RANIBIZUMAB

11.99.0. – various

Use

HAM – Human medicine

pharmaceutical form

LSINJ – Solution for injection

Remedy code

BT – biological medicines

Dispensing categories

B – Dispensed on prescription by a physician or veterinarian (B)

Authorisation status

Z – approved

Authorisation number

69068

Basic authorisation number

57664

Initial registration date

8/4/2023

Expiry date

8/3/2028

Dosage strength

Name

Ranivisio 10 mg/mL, Injektionslösung in Durchstechflasche

Field of application

Dosage strength number

Authorisation status

Z – approved

Package

GTIN**

7680690680015

Trade status*

In trade from / since 8/4/2023

Status

A/R – Authorised / referenced

Package size

1 vial(s)

Package code

001

Authorisation status

Z – approved

Declaration

Component

Active substance

10 mg ranibizumabum

Excipient

histidinum
histidini hydrochloridum monohydricum
trehalosum dihydricum
polysorbatum 20
aqua ad iniectabile

Spezialitätenliste***

Status

Date of deletion

Compulsory until

Public price (CHF)

620.60

Limitation points

None

Limitation

Yes

SB Deductible

10%

Generic

Authorisation holder

GLN**

7649995244001

Address

Bioeq AG
Grafenaustrasse 11
6300 Zug (ZG)

Date of revision of the text

8/1/2025

Information for prof.

Leaflet

Report error

Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.